[1]
2026. Bladder Cancer Diagnosis and Monitoring Based on Urine Survivin (BIRC5) Bioluminescence-Based Immunoassay. Voprosy onkologii. 72, 2 (May 2026), OF-2510. DOI:https://doi.org/10.37469/0507-3758-2026-72-2-OF-2510.